Clinical Trial Update: Renal Allograft Tolerance Through Mixed Chimerism (Belatacept) [Phase 1]

View source ↗

Summary

Phase 1 trial investigating renal allograft tolerance using mixed chimerism with Belatacept has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Kidney Failure

Drugs mentioned

• belatacept (belatacept)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Kidney Failure, Chronic, Renal Insufficiency | Phase 1 | Status: COMPLETED | Results posted: 2021-09-02